Market Value261,839,408
Total Holdings52
File Date2025-08-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
AVR / Anteris Technologies Global Corp.
MRUS / Merus N.V.
EMBC / Embecta Corp.
INMB / INmune Bio, Inc. Put
ENTA / Enanta Pharmaceuticals, Inc.
ANIP / ANI Pharmaceuticals, Inc.
PRQR / ProQR Therapeutics N.V.
AQST / Aquestive Therapeutics, Inc.
IDXX / IDEXX Laboratories, Inc. Put
HUMAW / Humacyte, Inc. - Equity Warrant
DRUG / Bright Minds Biosciences Inc.
CNC / Centene Corporation
ALEC / Alector, Inc.
SNY / Sanofi - Depositary Receipt (Common Stock)
ZBH / Zimmer Biomet Holdings, Inc.
AKRO / Akero Therapeutics, Inc.
ICLR / ICON Public Limited Company
TARA / Protara Therapeutics, Inc.
LH / Labcorp Holdings Inc.
TFX / Teleflex Incorporated
HAE / Haemonetics Corporation
SLNO / Soleno Therapeutics, Inc. Put
IRWD / Ironwood Pharmaceuticals, Inc.
PRAX / Praxis Precision Medicines, Inc.
ETNB / 89bio, Inc.
ANNX / Annexon, Inc.
OVID / Ovid Therapeutics Inc.
APRE / Aprea Therapeutics, Inc.
SVRA / Savara Inc.
TVTX / Travere Therapeutics, Inc.
GMED / Globus Medical, Inc.
ERAS / Erasca, Inc.
VIR / Vir Biotechnology, Inc.
RCKTW / Rocket Pharmaceuticals, Inc. - Equity Warrant
VTYX / Ventyx Biosciences, Inc.
CNTX / Context Therapeutics Inc.
ALGS / Aligos Therapeutics, Inc.
AORT / Artivion, Inc.
NBIX / Neurocrine Biosciences, Inc.
MRK / Merck & Co., Inc.
BMRN / BioMarin Pharmaceutical Inc.
DNTH / Dianthus Therapeutics, Inc.
FHTX / Foghorn Therapeutics Inc.
AVNS / Avanos Medical, Inc.
SEPN / Septerna, Inc.
TERN / Terns Pharmaceuticals, Inc.
TYRA / Tyra Biosciences, Inc.
AVTX / Avalo Therapeutics, Inc.
MODD / Modular Medical, Inc.
PMVP / PMV Pharmaceuticals, Inc.
ATXS / Astria Therapeutics, Inc.
MMS / Maximus, Inc.
NYXH / Nyxoah SA
IDYA / IDEAYA Biosciences, Inc.
TELA / TELA Bio, Inc.
SENS / Senseonics Holdings, Inc.
BOLD / Boundless Bio, Inc.
NMTC / NeuroOne Medical Technologies Corporation
VXRT / Vaxart, Inc.
LIFE / aTyr Pharma, Inc. Put
MBX / MBX Biosciences, Inc.
NXTC / NextCure, Inc.
EWTX / Edgewise Therapeutics, Inc.
IRON / Disc Medicine, Inc.